Clinical economics review: Liver transplantation

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 3, 1997, Pages 445-451

  O'Grady, J G ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; DRUG COST; ECONOMIC ASPECT; GRAFT REJECTION; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITALIZATION; KIDNEY FAILURE; LIVER DISEASE; LIVER TRANSPLANTATION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SURVIVAL RATE;

EID: 0030743226     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.00164.x     Document Type: Review

References (35)

1. Dean M. Is your treatment economic, effective, efficient? Lancet 1991; 337: 480-1.
2. Bodger K, Daly MJ, Heatley RV, Williams DRR. Clinical economics in gastroenterology. Aliment Pharmacol Ther 1996; 10: 55-61.
3. Ramage JK, Wong P, Hayllar K, Williams R. Overall survival results: quality of life and management. In: Williams R, Portmann B, Tan K-C, eds. The Practice of Liver Transplantation. London: Churchill Livingstone, 1995: 259-70.
4. Evans RW, Manninen DL, Dong FB. An economic analysis of liver transplantation. Gastroenterol Clin N Am 1993; 22: 451-73.
5. McPeake JR, Portmann B. Hepatic malignancy. Budd-Chiari syndrome and space-occupying conditions. In: Williams R, Portmann B, Tan K-C, eds. The Practice of Liver Transplantation. London: Churchill Livingstone, 1995: 57-71.
6. Penn I. Hepatic transplantation for primary and metastatic cancer of the liver. Surgery 1991; 110: 726-34.
7. McPeake JR, O'Grady JG, Zaman S, et al. Liver transplantation for primary hepatocellular carcinoma: tumour size and number determines outcome. J Hepatol 1993; 18: 226-34.
8. O'Grady JG, Smith HM, Davies SE, et al. Hepatitis B reinfection after orthotopic liver transplantation: serological and clinical implications. J Hepatol 1992; 14: 104.
9. Samuel D, Bismuth H. Liver transplantation for hepatitis B. In: Lake JR, ed. Advances in liver transplantation. Gastroenterol Clin N Am 1993; 22: 271-83.
10. Shaw BW Jr, Wood RP, Gordon RD, Iwatsuki S, Gillquist WP, Starzl TF. Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation. Semin Liver Dis 1985; 5: 385-93.
11. Kim WR, Therneau TM, Evans RW, Steers JL, Wiesner RH, Dickson ER. Can resource utilization and quality of life posttransplant be predicted based on preoperative variables? Hepatology 1996; 24: 301A (Abstract).
12. Brown RS, Lake JR, Ascher NL, Emond JC, Roberts JP. Predictors of the cost of liver transplantation. Hepatology 1996; 24: 299A (Abstract).
13. Spanier TB, Klein RD, Nasraway SA, et al. Multiple organ failure after liver transplantation. Crit Care Med 1995; 23: 466-73.
14. Muto P, Freeman RB, Haugg CE, Lu A, Rohrer RJ. Liver Transplant candidate stratification systems. Implications for third-party payors and organ allocation. Transplantation 1994; 57: 306-8 (Letter).
15. Aboulijoud MS, Baliad P, Hocking N, et al. Managed care strategies in liver transplantation: Is there a clinical benefit? Hepatology 1996; 24: 243A (Abstract).
16. Buroughs AK, Blake J, Thorne S, Else M, Rolles K. Comparative hospital costs of liver transplantation and the treatment of complications of cirrhosis. A prospective study. Eur J Gastroenterol Hepatol 1992; 4: 123-8.
17. Williams R, Tan KC. Requirement of staff and facilities. In: Williams R, Portmann B, Tan K-C, eds. The Practice of Liver Transplantation. London: Churchill Livingstone, 1995: 3-10.
18. McKenna M, Alexander G, Jones M, Hutton J. Economic analysis of tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Eur Hosp Pharm 1996; 2:
19. European FK506 Multicentre Liver Study Group. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994; 344: 423-8.
20. Staschak S, Wagner S, Block G, et al. A cost comparison of liver transplantation with FK506 or CyA as the primary immunosuppressive agent. Transplant Proc 1990; 22 (Suppl. 1): 47-9.
21. Lake JR, Gorman KJ, Esquivel CO, et al. The impact of immunosuppressive regimens on the cost of liver transplantation - Results from the U.S. FK506 multicenter trial. Transplantation 1995; 60: 1089-95.
22. Ascher NL, Roberts JP, Lake JR. The use of older donor livers is associated with increased cost of liver transplantation. Hepatology 1996; 24: 183A (Abstract).
23. Bonsel GJ, Klompmaker IJ, Essink-Bot ML, Habbema JDF, Slooff MJH. Cost-effectiveness analysis of the Dutch liver transplantation programme. Trans Proc 1990; 22: 1481-4.
24. Emond JC, Aran PP, Whitington PF, Broelsch CE, Baker AL. Liver transplantation in the management of fulminant hepatic failure. Gastroenterology 1989; 96: 1583-5.
25. Ascher NL, Lake JR, Emond JC, Roberts JP. Liver transplantation for fulminant hepatic failure. Arch Surg 1993; 128: 677-82.
26. Castells A, Salmeron JM, Navasa M, et al. Liver transplantation for acute liver failure: analysis of applicability. Gastroenterology 1993; 1056: 532-8.
27. Munoz SJ, Moritz MJ, Martin P, Jarrell BE, Maddrey WC. Liver transplantation for fulminant hepatocellular failure. Trans Proc 1993; 25: 1773-5.
28. Mirza DF, Mohamed R, Mutimer DJ, McMaster P. Timing and candidacy for transplantation in acute liver failure: the European experience. Liver Transplant Surg 1995; 1: 182-6.
29. O'Grady JG, Wendon J, Tan KC, et al. Liver transplantation after paracetamol overdose. Br Med J 1991; 303: 221-3.
30. Sussman NL, Gislason G, Conlin CA, Kelly JH. The Hepatix extracorporeal liver assist device: initial clinical experience. Artif Organs 1994; 18: 390-6.
31. Ellis AJ, Wendon J, Hughes R, et al. The extracorporeal liver assist device in acute liver failure: design and testing of a controlled trial protocol. Hepatology 1996; 24: 1446-51.
32. Demetriou AA, Rozga J, Podesta, E. et al. Early clinical experience with a hybrid bioartificial liver. Scand J Gastroenterol 1995; 30 (Suppl.): 111-7.
33. Lowe D, O'Grady J, McEwen J, Williams R. Quality of life following liver transplantation: a preliminary report. J R Coll Physicians 1990; 24: 43-50.
34. Tarter RE, Switala J, Plail J, Havrilla J, van Thiel DH. Severity of hepatic encephalopathy before liver transplantation is associated with quality of life after transplantation. Arch Intern Med 1992; 152: 2097-101.
35. Stewart SM, Hiltebeitel C, Nici J, et al. Neuropsychological outcome of pediatric liver transplantation. Pediatrics 1991; 87: 367-76.